As of 2026-03-19, the Relative Valuation of Dechra Pharmaceuticals PLC (DPH.L) is (449.70) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on Relative Valuation is -111.6%.
The range of the Relative Valuation is (410.73) - (477.39) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 19.5x | 18.5x |
| Forward P/E multiples | 16.6x - 19.5x | 18.2x |
| Fair Price | (410.73) - (477.39) | (449.70) |
| Upside | -110.6% - -112.3% | -111.6% |
| Date | P/E |